Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid and Sodium Hyaluronate Hydrodilatation
NCT05861570Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- May 2023
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of sodium hyaluronate in adhesive capsulitis (AC) (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Change in Pain Intensity (Visual Analog Scale) at 12 weeks. Status: unknown.
02
Drugs
sodium hyaluronate
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT05861570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05861570.